The University of Southampton
University of Southampton Institutional Repository

A protocol to determine valid in young cystic fibrosis patients

A protocol to determine valid in young cystic fibrosis patients
A protocol to determine valid in young cystic fibrosis patients
Objectives: measuring aerobic fitness (VO2max) via a maximal cardiopulmonary exercise test is an important clinical tool in cystic fibrosis. This study sought to establish: (1) the validity of traditional criteria to verify maximal efforts during a ramp cardiopulmonary exercise test; and (2) whether the VO2 measured during an exhaustive cardiopulmonary exercise test represents a valid VO2max in paediatric patients, using a subsequent exhaustive supramaximal (Smax) exercise test.

Design: cross-sectional.

Methods: fourteen patients (7–18 years; 10 males) completed an exhaustive ramp test to determine VO2max. Following 15-min recovery, Smax (110% ramp peak power output) was performed.

Results: ramp test VO2peak was significantly higher than VO2 documented at traditional endpoint criteria, including a RER of 1.00 (0.99 ± 0.47 L min−1 vs. 1.83 ± 0.78 L min−1, p < 0.001) and 1.10 (1.36 ± 0.59 L min−1 vs. 1.83 ± 0.78 L min−1, p < 0.001), despite 100% of patients satisfying these two criteria. Only 23% and 75% of patients satisfied the 95% age-predicted heart rate (HR) maximum and 180 b min−1 criteria. Whilst mean ramp and Smax VO2peak were not significantly different (1.83 ± 0.78 L min−1 vs. 1.82 ± 0.67 L min−1; p = 0.88), at the individual level Smax elicited a ‘meaningful’ (>9%) increase in VO2peak (range 9.9–38.3%) compared with VO2peak from the ramp test in 3 of 14 cases (21.4%).

Conclusions - Traditional criteria significantly underestimate VO2max in young cystic fibrosis patients. Conversely, Smax can confirm when ‘true’ VO2max is achieved. The use of Smax following cardiopulmonary exercise test represents an appropriate method to measure VO2max in young cystic fibrosis patients.
1440-2440
539-544
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Barker, Alan R.
a930df01-4fdb-44a9-8014-fe21e5ea3b04
Oades, Patrick J.
a75b6826-6d88-47a9-9656-f0f79a9b3a63
Williams, Craig A.
c96ddcec-3c7e-4686-b831-cbb4f004ccb0
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Barker, Alan R.
a930df01-4fdb-44a9-8014-fe21e5ea3b04
Oades, Patrick J.
a75b6826-6d88-47a9-9656-f0f79a9b3a63
Williams, Craig A.
c96ddcec-3c7e-4686-b831-cbb4f004ccb0

Saynor, Zoe L., Barker, Alan R., Oades, Patrick J. and Williams, Craig A. (2013) A protocol to determine valid in young cystic fibrosis patients. Journal of Science and Medicine in Sport, 16 (6), 539-544. (doi:10.1016/j.jsams.2013.01.010).

Record type: Article

Abstract

Objectives: measuring aerobic fitness (VO2max) via a maximal cardiopulmonary exercise test is an important clinical tool in cystic fibrosis. This study sought to establish: (1) the validity of traditional criteria to verify maximal efforts during a ramp cardiopulmonary exercise test; and (2) whether the VO2 measured during an exhaustive cardiopulmonary exercise test represents a valid VO2max in paediatric patients, using a subsequent exhaustive supramaximal (Smax) exercise test.

Design: cross-sectional.

Methods: fourteen patients (7–18 years; 10 males) completed an exhaustive ramp test to determine VO2max. Following 15-min recovery, Smax (110% ramp peak power output) was performed.

Results: ramp test VO2peak was significantly higher than VO2 documented at traditional endpoint criteria, including a RER of 1.00 (0.99 ± 0.47 L min−1 vs. 1.83 ± 0.78 L min−1, p < 0.001) and 1.10 (1.36 ± 0.59 L min−1 vs. 1.83 ± 0.78 L min−1, p < 0.001), despite 100% of patients satisfying these two criteria. Only 23% and 75% of patients satisfied the 95% age-predicted heart rate (HR) maximum and 180 b min−1 criteria. Whilst mean ramp and Smax VO2peak were not significantly different (1.83 ± 0.78 L min−1 vs. 1.82 ± 0.67 L min−1; p = 0.88), at the individual level Smax elicited a ‘meaningful’ (>9%) increase in VO2peak (range 9.9–38.3%) compared with VO2peak from the ramp test in 3 of 14 cases (21.4%).

Conclusions - Traditional criteria significantly underestimate VO2max in young cystic fibrosis patients. Conversely, Smax can confirm when ‘true’ VO2max is achieved. The use of Smax following cardiopulmonary exercise test represents an appropriate method to measure VO2max in young cystic fibrosis patients.

This record has no associated files available for download.

More information

Accepted/In Press date: 31 January 2013
e-pub ahead of print date: 18 March 2013
Published date: 1 November 2013

Identifiers

Local EPrints ID: 494041
URI: http://eprints.soton.ac.uk/id/eprint/494041
ISSN: 1440-2440
PURE UUID: 0b4807a3-733f-4909-a0c5-b148bf092d51
ORCID for Zoe L. Saynor: ORCID iD orcid.org/0000-0003-0674-8477

Catalogue record

Date deposited: 20 Sep 2024 16:33
Last modified: 21 Sep 2024 02:14

Export record

Altmetrics

Contributors

Author: Zoe L. Saynor ORCID iD
Author: Alan R. Barker
Author: Patrick J. Oades
Author: Craig A. Williams

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×